The 2009 H1N1 influenza pandemic: a case study of how modeling can assist all stages of vaccine decision-making.
During the 2009 H1N1 influenza pandemic nearly every decision associated with new vaccine development and dissemination occurred from the Spring of 2009, when the novel virus first emerged, to the Fall of 2009, when the new vaccines started reaching the thighs, arms and noses of vaccinees. In many ways, 2009 served as a crash course on how mathematical and computational modeling can assist all aspects of vaccine decision-making. Modeling influenced pandemic vaccine decision-making, but not to its fullest potential. The 2009 H1N1 pandemic demonstrated that modeling can help answer questions about new vaccine development, distribution, and administration such as (1) is a vaccine needed, (2) what characteristics should the vaccine have, (3) how should the vaccine be distributed, (4) who should receive the vaccine and in what order and (5) when should vaccination be discontinued? There is no need to wait for another pandemic to enhance the role of modeling, as new vaccine candidates for a variety of infectious diseases are emerging every year. Greater communication between decision makers and modelers can expand the use of modeling in vaccine decision-making to the benefit of all vaccine stakeholders and health around the globe.
University of Pittsburgh School of Medicine and Graduate School of Public Health University of Pittsburgh, Pittsburgh, PA, USA. BYL1@pitt.edu
Bruce Y
BY
Lee
Ann E
AE
Wiringa
D003657:Decision Making; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology / Q000302:isolation & purification*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology / Q000600:supply & distribution*; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control* / Q000821:virology; D015233:Models, Statistical; D058873:Pandemics / Q000517:prevention & control*
D007252:Influenza Vaccines
Influenza Other Respir Viruses. 2010 Mar;4(2):61-72
20167046
J Public Health Manag Pract. 2010 May-Jun;16(3):252-61
20035236
PLoS One. 2010 Jun 23;5(6):e11284
20585642
Vaccine. 2010 Jul 12;28(31):4875-9
20483192
Vaccine. 2010 Apr 1;28(16):2806-9
19782109
Am J Manag Care. 2010 Mar;16(3):e75-e85
20205492
Am J Prev Med. 2010 Nov;39(5):e21-9
20965375
Nature. 2006 Jul 27;442(7101):448-52
16642006
Nature. 2005 Sep 8;437(7056):209-14
16079797
Am J Prev Med. 2010 Mar;38(3):247-57
20042311
Vaccine. 2009 Nov 23;27(50):7110-5
19786135
Vaccine. 2010 Mar 11;28(12):2465-71
20064479
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44
18332436
Vaccine. 2010 Aug 23;28(37):5952-9
20620168
Transl Res. 2008 Jun;151(6):275-87
18514138
MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8
19713882
Obstet Gynecol. 2009 Nov;114(5):971-980
20168096
Clin Infect Dis. 2009 Dec 15;49(12):1784-92
19911967
Science. 2005 Aug 12;309(5737):1083-7
16079251
Epidemiol Infect. 2010 Oct;138(10):1472-81
20158932